{"id":"W2182997742","doi":"","title":"Is PazOP aNIb the Preferred fIrst-LINe treatmeNt fOr metastatIc reNaL ceLL carcINOma?","year":2013,"lang":"en","type":"article","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Pazopanib; Sunitinib; Medicine; Renal cell carcinoma; Oncology; Internal medicine; Cabozantinib; Kidney cancer; Tyrosine-kinase inhibitor; Clinical trial; Cancer","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01115895,0.001015001,0.002674102,0.001211736,0.003090749,0.003146504,0.004709548,0.0425116,0.008480174],"category_scores_gemma":[0.06915015,0.0008699267,0.002121676,0.001284869,0.004510553,0.00743879,0.001466868,0.05032261,0.00617583],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.007221474,"about_ca_system_score_gemma":0.01023517,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01379553,"about_ca_topic_score_gemma":0.01859359,"domain_scores_codex":[0.9920209,0.002793815,0.000981783,0.001188327,0.002467904,0.0005472274],"domain_scores_gemma":[0.945438,0.03441801,0.003234254,0.0006490739,0.01281016,0.003450367],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001021349,0.00001211664,0.00007544106,0.0002538414,0.00003298474,0.0001051887,0.0000688432,0.00003556569,0.00007290232,0.00159794,0.9891531,0.008489917],"study_design_scores_gemma":[0.0003001801,0.0001192298,0.0005973135,0.002429619,0.0001374859,0.000524287,0.000438707,0.0001727276,0.0002533023,0.008090876,0.9868312,0.0001051497],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.00008397359,0.006660944,0.00004782298,0.9571283,0.03552069,0.000004609069,0.0000714632,0.00001064898,0.0004716738],"genre_scores_gemma":[0.001716513,0.005920462,0.0001179124,0.9255688,0.06567205,0.00001435992,0.00004376189,0.00001925159,0.0009269494],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.0425116,"threshold_uncertainty_score":0.05901486,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07935437275349255,"score_gpt":0.2916583257885231,"score_spread":0.2123039530350305,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}